Most cancerous polyps found during a colonoscopy are caught early enough that the endoscopist removes them on the spot, and for many patients that removal turns out to be the only treatment they need. What happens next depends almost entirely on what the pathologist sees under the microscope: how deep the cancer cells have grown, whether they have reached the edges of the removed tissue, and whether they show signs of spreading. That pathology report is the fork in the road, splitting patients into a group that can be monitored with follow-up colonoscopies and a group that needs surgery to remove part of the colon.
How Often a Colonoscopy Turns Up Cancer in a Polyp
Finding cancer inside a polyp is uncommon relative to the total number of polyps removed. Most polyps are small and benign. In a screening study of adults aged 40 to 49, about 9 percent had tubular adenomas and roughly 3.5 percent had advanced neoplasms, but none were cancerous.1PubMed. Results of screening colonoscopy among persons 40 to 49 years of age Size matters enormously here. Among polyps under 10 mm, fewer than 1 percent show advanced features like high-grade changes or invasive cancer.2PubMed. Prevalence of advanced histological features in diminutive and small colon polyps Once polyps cross the 10 mm threshold, the picture shifts. In one large analysis, about 1 percent of polyps between 10 and 19 mm contained cancer, rising to 6 percent for polyps 20 to 29 mm and roughly 38 percent for polyps 30 mm or larger.3Gastroenterology. Low Rates of Cancer or High-Grade Dysplasia in Colorectal Polyps Collected From Computed Tomography Colonography Screening So the larger the polyp, the more seriously the clinical team takes it, and the more carefully the pathologist scrutinizes the tissue.
What Happens in the Procedure Room
When an endoscopist sees a suspicious polyp during the colonoscopy, the standard practice is to remove it right then. Small and medium polyps are typically snared off using a wire loop, sometimes with an electrical current to cut and cauterize the base. This is called a polypectomy, and it is part of the routine workflow of a colonoscopy. For larger or flatter lesions that cannot be easily snared, more advanced endoscopic techniques are used. Endoscopic mucosal resection lifts the lesion off the colon wall with an injection of fluid beneath it, then removes it in one or more pieces. Endoscopic submucosal dissection goes a step further, allowing the endoscopist to carve out the lesion in a single intact piece.
A meta-analysis of randomized trials found that submucosal dissection led to significantly lower recurrence rates compared with mucosal resection, with no meaningful difference in complications like bleeding or perforation between the two.4PubMed. Recurrence rates following endoscopic mucosal resection versus endoscopic submucosal dissection for colorectal polyps: a systematic review and meta-analysis of randomized controlled trials The trade-off is that submucosal dissection is technically harder, takes longer, and is not available at every center. When the lesion is removed in a single piece, the pathologist gets a much cleaner view of the margins, which becomes critical for the decision-making that follows.
If the endoscopist suspects the polyp could be cancerous or the patient might need surgery later, the polypectomy site is often tattooed. A small injection of sterile ink is placed near the site so that a surgeon can find the exact spot in the colon if an operation is needed weeks later. Studies have found this technique safe and highly effective for helping surgeons locate previously removed lesions.5PubMed. Safety of preoperation endoscopic tattoo with india ink for identification of colonic lesions6PubMed. A two-step method for marking polypectomy sites in the colon and rectum
The Pathology Report and Why It Drives Everything
The removed polyp goes to a pathology lab, and the report that comes back is the single most important document in the process. Cancer in a polyp is not all the same. Pathologists draw a sharp line between cancer cells that have not yet breached a key boundary layer in the colon wall (called the muscularis mucosa) and cancer cells that have pushed through into the deeper tissue beneath it (the submucosa). When cancer stays above that line, the polypectomy is generally considered curative on its own.7PubMed Central. Malignant colorectal polyps When cancer crosses into the submucosa, the polyp is classified as a T1 tumor, and the conversation about whether surgery is needed begins.
For polyps that sit on a stalk (pedunculated polyps), pathologists describe how far down the cancer cells have traveled using a four-level system. Cancer limited to the head of the polyp is level 1. Cancer reaching the neck is level 2. Cancer invading the stalk itself is level 3, and cancer pushing into the tissue below the stalk is level 4.8Gastroenterology. What Happens If a Cancerous Polyp Is Found During a Colonoscopy? – Section: Histologic Classification Systems for Depth of Cancer Invasion For flat or sessile polyps without a stalk, a different system divides the submucosa into three horizontal zones, from shallow to deep. The deeper the invasion, the higher the risk that cancer cells have already traveled to nearby lymph nodes.
The Factors That Determine Whether You Need Surgery
Depth of invasion is just one factor on the pathology checklist. Several others weigh heavily in the decision.
- Resection margin: Did the pathologist find cancer cells at or near the cut edge of the removed polyp? A clear margin is the strongest reassurance. In one study, none of the patients with clear resection margins had any adverse outcomes, regardless of other risk factors. Among those with involved margins who went to surgery, nearly 60 percent had residual tumor in the bowel wall, and some had lymph node spread.9PubMed Central. Management of colorectal polyp cancers
- Lymphovascular invasion: If cancer cells are seen inside blood vessels or lymphatic channels in the polyp tissue, the odds of lymph node spread jump dramatically. A large database analysis found that lymphovascular invasion was the single strongest predictor, roughly sixfold higher odds of lymph node involvement.10The American Journal of Surgery. Predictors of lymph node metastasis in malignant colonic polyps: A National Cancer Database analysis
- Tumor grade: Poorly differentiated (high-grade) cancer cells behave more aggressively and are more likely to have spread. High-grade disease was an independent predictor of lymph node involvement in the same analysis.
- Tumor budding: Small clusters of cancer cells breaking away from the main tumor mass, visible under the microscope, signal a more invasive biology. One study found that tumor budding was the only feature significantly associated with lymph node spread in T1 cancers, with high sensitivity for identifying those at risk.11PubMed Central. Tumor budding as a risk factor of lymph node metastasis in submucosal invasive T1 colorectal carcinoma: a retrospective study
When all of these factors look favorable — clear margins, well-differentiated cells, no lymphovascular invasion, shallow submucosal invasion — polypectomy alone is considered adequate treatment. A landmark study followed patients with favorable features after polypectomy for an average of over six years: none developed metastatic disease.12Gastroenterology. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Among patients with unfavorable features in the same study, more than 40 percent went on to have residual or metastatic cancer found at surgery or during follow-up.
When Surgery Is Recommended
If the pathology report shows one or more high-risk features, a surgeon will typically recommend removing the segment of colon where the polyp was located, along with the surrounding lymph nodes. This is a partial colectomy, and it is done to check for cancer that may have spread beyond the polyp itself and to remove any residual disease at the polypectomy site.
The recommendation is strongest for sessile (flat) polyps with invasive cancer. Because these polyps lack a stalk, cancer cells have a shorter path to the deeper layers of the colon wall and to nearby lymph nodes. An early study of sessile malignant polyps found that among patients who went to surgery after colonoscopic removal, a meaningful fraction had either residual cancer at the polypectomy site or positive lymph nodes, supporting the general recommendation for surgical resection of sessile cancerous polyps when the patient’s overall health allows it.13PubMed. Malignant colon polyps–cure by colonoscopy or colectomy? The surgical recommendations have been refined over the decades to also account for the microscopic features: incomplete excision, poorly differentiated tumor, invasion of the resection line, stalk invasion, and involvement of vessels or lymphatic channels each point toward surgery.14PubMed Central. Patient management after endoscopic removal of the cancerous colon adenoma
Modern colectomies are usually performed laparoscopically, with small incisions, and most patients go home within a few days. The removed segment of colon is examined by the pathologist to determine the final cancer stage, which then guides any discussion about additional treatment such as chemotherapy. For many T1 cancers, the surgery itself is the cure and no further treatment is needed.
Long-Term Survival After Treatment
The prognosis for cancerous polyps caught during colonoscopy is overwhelmingly good, regardless of whether the patient ends up with polypectomy alone or surgery. A study tracking long-term outcomes found no cancer-related deaths in either group. Five-year survival was about 95 percent for patients treated with polypectomy alone and 82 percent for those who had colectomy — a difference that was not statistically significant and likely reflects the fact that the surgery group had higher-risk tumors and tended to be older or sicker.15PubMed. Long-term survival after treatment of malignant colonic polyps The key point is that cancer found this early, within a polyp, is fundamentally different from cancer discovered after it has grown through the full thickness of the colon wall or spread to distant organs. The colonoscopy caught it before it had the chance to become advanced-stage disease.
Recovery and Quality of Life
One of the real practical questions patients have is how different life is after endoscopic treatment versus surgery. A study comparing the two found that the perceived time to full recovery was dramatically different: roughly 20 days for patients treated endoscopically versus about 111 days for surgery patients. Despite that gap in recovery time, the two groups ended up with comparable overall quality of life once they had healed. Patients who had endoscopic treatment did not report more fear of cancer coming back than those who had surgery, which is reassuring for anyone worried that a less invasive approach means less peace of mind.16PubMed. Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection
There is a psychological dimension to the whole experience worth acknowledging. Being told you need surveillance colonoscopies after a polyp finding naturally raises some worry about bowel cancer. A study looking at this found that bowel cancer worry and attention to bowel symptoms did increase initially in people assigned to surveillance, but both faded over time to levels similar to those seen in people who had polyps removed without needing further follow-up.17PubMed. The psychological impact of being offered surveillance colonoscopy following attendance at colorectal screening using flexible sigmoidoscopy The anxiety is real, but it tends to be temporary.
The Cost Difference Between Endoscopic and Surgical Treatment
Cost is not usually the primary driver of the treatment decision — the pathology is — but the financial difference is substantial. For complex colon polyps, endoscopic resection costs roughly a third of what surgical resection costs per patient, with comparable or even slightly better outcomes in quality-adjusted life years.18Gastrointestinal Endoscopy. Economic analysis of endoscopic resection versus surgical resection for complex colon polyps A separate analysis found endoscopic submucosal dissection had roughly a 43 percent cost reduction compared to laparoscopic colectomy.19PubMed. Management of the colorectal polyp referred for resection: A case-matched comparison of advanced endoscopic surgery and laparoscopic colectomy For rectal polyps specifically, endoscopic resection was less expensive than transanal surgical approaches while yielding equivalent quality-of-life outcomes.20PubMed. Cost Effectiveness of Endoscopic Resection vs Transanal Resection of Complex Benign Rectal Polyps
These numbers matter because they support the general trend in gastroenterology toward handling as much as possible endoscopically. When the pathology is favorable, avoiding surgery is not just easier on the patient — it is dramatically easier on the healthcare system. The challenge is that this calculus only works when the endoscopic resection is technically complete and the pathology confirms low-risk features. An incomplete endoscopic removal that leads to a delayed surgery can end up costing more in every sense.
Complications of Polyp Removal
Polypectomy is generally safe, but bleeding is the most common complication. It occurs in roughly 0.3 to 6 percent of polypectomies, a wide range that reflects differences in polyp size, technique, and patient factors like blood-thinning medications.21PubMed Central. How do I manage post-polypectomy bleeding? Most post-polypectomy bleeding stops on its own or is managed endoscopically during a repeat procedure. Perforation — a small hole in the colon wall — is rarer and more serious, but still uncommon and usually manageable when it occurs in an experienced center. If you have been taking aspirin or another anticoagulant, your doctor will typically discuss the timing of stopping and restarting these medications around the procedure.
When the Polyp Raises Questions About Inherited Risk
Occasionally, the pathology lab runs additional tests on the polyp tissue that go beyond staging. One increasingly common test checks for defects in mismatch repair proteins, which are part of the cell’s DNA-repair machinery. Loss of these proteins in a polyp can be a clue to Lynch syndrome, an inherited condition that dramatically raises the lifetime risk of colorectal and other cancers. In a screening study of over 500 patients undergoing polyp removal, about 1.2 percent of adenomas showed loss of mismatch repair protein expression, and genetic testing of those patients identified confirmed or suspected inherited mutations in a subset.22BioMed Central / PubMed Central. Single-center study of Lynch syndrome screening in colorectal polyps
Finding Lynch syndrome in a single patient has ripple effects for the whole family. First-degree relatives can be offered genetic testing and, if positive, placed on an accelerated screening schedule that catches cancers years earlier than they would otherwise be found. The polyp that triggered this workup does not need to be cancerous for the testing to be valuable, but a cancerous polyp in a younger patient is one of the strongest prompts to run these tests.
Artificial Intelligence in the Procedure Suite
One developing area is the use of AI during colonoscopy to help endoscopists decide in real time whether a polyp looks cancerous. A trial comparing AI-assisted optical diagnosis to standard visual inspection found that the AI system matched experienced endoscopists in sensitivity and specificity for identifying neoplastic polyps, but the AI made high-confidence assessments far more often — roughly 93 percent of the time versus 74 percent for the endoscopists alone.23NEJM Evidence. Real-Time Artificial Intelligence-Based Optical Diagnosis of Neoplastic Polyps during Colonoscopy The practical benefit is not so much raw accuracy as consistency: AI does not get tired during a long list of procedures, and it can flag subtle polyps that a fatigued eye might underestimate. This technology is not yet a replacement for the pathology lab, which still makes the definitive call, but it is increasingly shaping what happens in the procedure room itself.